The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Up for the game.
Lets cr8 a whatsapp grp. We cant be taken for a ride.
Until and unless these people commit to buy large holdings, do not approve anything.
We now need absolute information about the products, stages et. We have nothing much left to loose.
Let this come down to their credibility. Spread the word in the market about how inefficient this fking team is.
Until and unless they give a very clear picture with facts and figures, I think we should let this go burst now.
I don't want to live with this pain forever.
Its only them who are getting richer. Since last one, they have raked in £££ in salaries and want to keep doing this again.
Just seen the emails, not sure what to make of it.
Gutted though. Had been following this for last 6 year, roughly £40k invested.
Not sure why they have to call admin when the only thing we are waiting for is 201 results.
They better stop taking salaries for few weeks until situation improves and hopefully all will be happy.
Founders: typically, founders create, develop and register IP rights (or other similar rights) before the incorporation of their company. They might, for instance, coin brand names, formulate algorithms, register domain names, develop the website, etc. Any IP created by the founder(s) prior to the incorporation of the company will be owned by the founders, not the company. Founders also tend not to enter into employment or consultancy agreements with the company for their services. As a consequence, IP developed by founders during the performance of their services after incorporation of the company will not ordinarily be owned by the company.
Employees: the basic rule is that the company will own the IP that its employees develop, provided it is created in the course of his/her employment. Exceptions exist, however, and employment agreements should always contain comprehensive provisions to ensure that IP is owned by the company.
Consultants (also known as independent contractors): unless there is a written contract in place that transfers ownership, the consultant will almost always own the IP that he/she/it creates. This is a very common issue and often requires the consultant to enter into a written contract to transfer ownership of the rights if such an agreement does not already exist.
So now the question is when was IP created and has GM been employed at that time.
Extract: Surprisingly and unexpectedly, the inventors have now demonstrated that targeting the SH3 domain of the tyrosine kinase, Src impairs the metastatic phenotype of fibrosarcoma and prostate cancer cells. The inventors have found that a peptide that binds to the SH3 domain of Src inhibits EGF-mediated processes known to be collectively involved in metastasis, such as DNA synthesis, motility and MMP secretion (see Example 1), and significantly reduces the incidence of lymph node metastases (see Example 2). Given that cell motility and MMP expression are known to be involved in metastasis (Jung et al, 2010; Cortes et al, 2008; Murray et al, 2012) the inventors believe that the effect will be apparent for other metastatic cancers also.
https://www.proactiveinvestors.co.uk/companies/news/222823/valirx-secures-us-patent-for-val201-cancer-drug-222823.html
Where does it says that its been granted to GM